当前位置:首页 - 行情中心 - 荣昌生物(688331) - 财务分析 - 现金流量表

荣昌生物

(688331)

  

流通市值:210.90亿  总市值:729.93亿
流通股本:1.63亿   总股本:5.64亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金765,811,447.082,690,967,408.682,229,797,482.861,062,768,898.97
  收到的税费返还-3,199.683,199.683,199.68
  收到其他与经营活动有关的现金4,796,924.8628,270,779.0126,135,188.3314,811,572.27
  经营活动现金流入小计770,608,371.942,719,241,387.372,255,935,870.871,077,583,670.92
  购买商品、接受劳务支付的现金87,523,962.53146,918,855.02104,074,192.6352,300,717.46
  支付给职工以及为职工支付的现金298,012,968.51,022,486,815.72776,054,088.56531,384,544.56
  支付的各项税费75,182,346.37153,666,642.53106,451,519.8676,394,469.64
  支付其他与经营活动有关的现金298,571,090.591,343,217,178.721,052,298,635.88663,043,194.53
  经营活动现金流出小计759,290,367.992,666,289,491.992,038,878,436.931,323,122,926.19
  经营活动产生的现金流量净额11,318,003.9552,951,895.38217,057,433.94-245,539,255.27
二、投资活动产生的现金流量:
  收回投资收到的现金661,881,458.682,150,000,0001,050,000,000250,000,000
  取得投资收益收到的现金2,667,417.43,250,378.421,606,295.09661,791.67
  处置固定资产、无形资产和其他长期资产收回的现金净额4,5002,130,338.941,610,219.631,414,066.73
  收到的其他与投资活动有关的现金-9,578,4009,578,4009,578,400
  投资活动现金流入小计664,553,376.082,164,959,117.361,062,794,914.72261,654,258.4
  购建固定资产、无形资产和其他长期资产支付的现金45,064,075.73200,006,319.47175,212,674.86120,552,809.81
  投资支付的现金598,909,456.462,170,600,694.881,167,127,956.2260,151,268.45
  投资活动现金流出小计643,973,532.192,370,607,014.351,342,340,631.06380,704,078.26
  投资活动产生的现金流量净额20,579,843.89-205,647,896.99-279,545,716.34-119,049,819.86
三、筹资活动产生的现金流量:
  吸收投资收到的现金27,728,930.75814,998,805.09783,623,475.65774,817,264.93
  取得借款收到的现金163,461,387.962,034,726,064.981,333,647,815.421,198,221,840.57
  收到其他与筹资活动有关的现金---1,836,362.93
  筹资活动现金流入小计191,190,318.712,849,724,870.072,117,271,291.071,974,875,468.43
  偿还债务支付的现金209,548,736.822,118,124,875.631,630,099,036.421,018,225,763.78
  分配股利、利润或偿付利息支付的现金12,927,033.4971,997,261.2566,397,042.9141,858,938.57
  支付其他与筹资活动有关的现金51,247,132.18107,644,447.9849,806,464.4134,454,700.63
  筹资活动现金流出小计273,722,902.492,297,766,584.861,746,302,543.741,094,539,402.98
  筹资活动产生的现金流量净额-82,532,583.78551,958,285.21370,968,747.33880,336,065.45
四、汇率变动对现金及现金等价物的影响-5,332,945.61-4,193,799.09-620,373.83-4,276,762.99
五、现金及现金等价物净增加额-55,967,681.55395,068,484.51307,860,091.1511,470,227.33
  加:期初现金及现金等价物余额1,154,598,527.93759,530,043.42759,530,043.42759,530,043.42
  期末现金及现金等价物余额1,098,630,846.381,154,598,527.931,067,390,134.521,271,000,270.75
补充资料:
  净利润-709,649,797.14--449,568,663.07
  资产减值准备-1,953,331.57--
  固定资产和投资性房地产折旧-249,580,354.82-125,411,013.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-249,580,354.82-125,411,013.43
  无形资产摊销-9,456,147.6-4,149,416.39
  长期待摊费用摊销-3,871,556.75-2,001,255.77
  待摊费用的减少-50,901.05--
  处置固定资产、无形资产和其他长期资产的损失-771,569.73--178,554.91
  固定资产报废损失-139,048.99-48,950.98
  公允价值变动损失--640,713,336.7--52,149.71
  财务费用-74,361,912.85-45,927,831.76
  投资损失--4,235,581.12-4,433,931.62
  存货的减少--720,374.08-18,121,441.28
  经营性应收项目的减少--1,023,109,780.18-56,657,676.2
  经营性应付项目的增加-579,989,654.23--91,496,853.28
  其他---12,139,512.52
  现金的期末余额-1,154,598,527.93-1,271,000,270.75
  减:现金的期初余额-759,530,043.42-759,530,043.42
  现金及现金等价物的净增加额-395,068,484.51-511,470,227.33
公告日期2026-04-292026-03-282025-10-312025-08-23
审计意见(境内)标准无保留意见
TOP↑